Sagent Pharmaceuticals, Inc.·4

Feb 25, 8:07 PM ET

Patterson Albert 4

4 · Sagent Pharmaceuticals, Inc. · Filed Feb 25, 2013

Insider Transaction Report

Form 4
Period: 2013-02-21
Patterson Albert
Senior VP, Operations
Transactions
  • Award

    Common Stock

    2013-02-21+6,99133,769 total
  • Award

    Stock Option to Buy

    2013-02-21+12,06712,067 total
    Exercise: $16.45Exp: 2023-02-21Common Stock (12,067 underlying)
Footnotes (1)
  • [F1]The option vests in four equal installments beginning on February 21, 2014.

Documents

1 file
  • 4
    rrd371538.xmlPrimary